References:
1 Parker SL, Tong T, Bolder S, Wingo PA: Cancer statistics, 1996. CA Cancer J Clin 1996;46:5-27
2 Adell G Boeryd B Franlund B Sjodahl R Hakansson L Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study. Eur J Surg (1996 Aug) 162(8):637-42
3 Eckhauser FE; Knol JA Surgery for primary and metastatic colorectal cancer Gastroenterol Clin North Am, 26(1):103-28 1997 Mar
4 Mainly cardiac and respiratory
5 Hafner GH Herrera L Petrelli NJ Morbidity and mortality after pelvic exenteration for colorectal adenocarcinoma. Ann Surg (1992 Jan) 215(1):63-7
6 de la Hunt MN Chan AY Karran SJ Postoperative complications: how much do they cost? Ann R Coll Surg Engl (1986 Jul) 68(4):199-202
7 Lechner P Lind P Binter G Cesnik H Anticarcinoembryonic antigen immunoscintigraphy with a 99mTc-Fab' fragment (Immu 4) in primary and recurrent colorectal cancer. A prospective study. Dis Colon Rectum (1993 Oct) 36(10):930-5
8 CEA-Scan package insert
9 Moffat FL Pinsky CM Hammershaimb L Petrelli NJ Patt YZ Whaley FS Goldenberg DM Immunomedics Study Group. Clinical utility of external immunoscintigraphy with the IMMU-4 99mTc-Fab' antibody fragment inpatients undergoing surgery for carcinoma of the colon and rectum. Results ofa pivotal Phase III trial. J Clin Oncol. 1996;14:2295-2305.
10 Jeffers MD O'Dowd GM Mulcahy H Stagg M O'Donoghue DP Toner M The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol (1994 Feb) 172(2):183-7
11 Adell G Boeryd B Franlund B Sjodahl R Hakansson L Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study. Eur J Surg (1996 Aug) 162(8):637-42
12 Audisio RA; Setti-Carraro P; Segala M; Capko D; Andreoni B; Tiberio G Follow-up in colorectal cancer patients: a cost-benefit analysis. Ann Surg Oncol, 3(4):349-57 1996 Jul
14 Lechner P Lind P Goldenberg DM Serial anti-CEA immunoscintigraphy (CEA-ScanŽ) for early diagnosis of recurrent rectal cancer. Presented as a poster at the 1998 World Federation of Surgical Oncology Societies; submitted for publication
15 CT, colonoscopy, and blood CEA levels at six months and 12 months postop, then annually for four years